1 Market Overview of Celecoxib Capsule

• 1.1 Celecoxib Capsule Market Overview
  • 1.1.1 Celecoxib Capsule Product Scope
  • 1.1.2 Market Status and Outlook
• 1.2 Global Celecoxib Capsule Market Size Overview by Region 2015 VS 2020 VS 2026
• 1.3 Global Celecoxib Capsule Market Size by Region (2015-2026)
• 1.4 Global Celecoxib Capsule Historic Market Size by Region (2015-2020)
• 1.5 Global Celecoxib Capsule Market Size Forecast by Region (2021-2026)
• 1.6 Key Regions, Celecoxib Capsule Market Size YoY Growth (2015-2026)
  • 1.6.1 North America Celecoxib Capsule Market Size YoY Growth (2015-2026)
  • 1.6.2 Europe Celecoxib Capsule Market Size YoY Growth (2015-2026)
  • 1.6.3 Asia-Pacific Celecoxib Capsule Market Size YoY Growth (2015-2026)
  • 1.6.4 Latin America Celecoxib Capsule Market Size YoY Growth (2015-2026)
  • 1.6.5 Middle East & Africa Celecoxib Capsule Market Size YoY Growth (2015-2026)

2 Celecoxib Capsule Market Overview by Type

• 2.1 Global Celecoxib Capsule Market Size by Type: 2015 VS 2020 VS 2026
• 2.2 Global Celecoxib Capsule Historic Market Size by Type (2015-2020)
• 2.3 Global Celecoxib Capsule Forecasted Market Size by Type (2021-2026)
• 2.4 50mg
• 2.5 100mg
• 2.6 200mg
• 2.7 400mg

3 Celecoxib Capsule Market Overview by Application

• 3.1 Global Celecoxib Capsule Market Size by Application: 2015 VS 2020 VS 2026
• 3.2 Global Celecoxib Capsule Historic Market Size by Application (2015-2020)
• 3.3 Global Celecoxib Capsule Forecasted Market Size by Application (2021-2026)
• 3.4 Rheumatoid Arthritis
• 3.5 Osteoarthritis
• 3.6 Acute Pain
• 3.7 Musculoskeletal Pain
• 3.8 Others

4 Global Celecoxib Capsule Competition Analysis by Players

• 4.1 Global Celecoxib Capsule Market Size (Million US$) by Players (2015-2020)
• 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celecoxib Capsule as of 2019)
• 4.3 Date of Key Manufacturers Enter into Celecoxib Capsule Market
• 4.4 Global Top Players Celecoxib Capsule Headquarters and Area Served
• 4.5 Key Players Celecoxib Capsule Product Solution and Service
• 4.6 Competitive Status
  • 4.6.1 Celecoxib Capsule Market Concentration Rate
  • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data

• 5.1 Pfizer
  • 5.1.1 Pfizer Profile
  • 5.1.2 Pfizer Main Business
  • 5.1.3 Pfizer Products, Services and Solutions
  • 5.1.4 Pfizer Revenue (US$ Million) & (2015-2020)
  • 5.1.5 Pfizer Recent Developments
• 5.2 Teva
  • 5.2.1 Teva Profile
  • 5.2.2 Teva Main Business and Company’s Total Revenue
  • 5.2.3 Teva Products, Services and Solutions
  • 5.2.4 Teva Revenue (US$ Million) (2015-2020)
  • 5.2.5 Teva Recent Development and Reaction to Covid-19
• 5.3 Mylan
  • 5.5.1 Mylan Profile
  • 5.3.2 Mylan Main Business
  • 5.3.3 Mylan Products, Services and Solutions
  • 5.3.4 Mylan Revenue (US$ Million) & (2015-2020)
  • 5.3.5 Apotex Recent Developments
• 5.4 Apotex
  • 5.4.1 Apotex Profile
  • 5.4.2 Apotex Main Business
  • 5.4.3 Apotex Products, Services and Solutions
  • 5.4.4 Apotex Revenue (US$ Million) & (2015-2020)
  • 5.4.5 Apotex Recent Developments
• 5.5 Lupin
  • 5.5.1 Lupin Profile
  • 5.5.2 Lupin Main Business
  • 5.5.3 Lupin Products, Services and Solutions
  • 5.5.4 Lupin Revenue (US$ Million) & (2015-2020)
  • 5.5.5 Lupin Recent Developments
• 5.6 HENGRUI MEDICINE
  • 5.6.1 HENGRUI MEDICINE Profile
  • 5.6.2 HENGRUI MEDICINE Main Business
  • 5.6.3 HENGRUI MEDICINE Products, Services and Solutions
  • 5.6.4 HENGRUI MEDICINE Revenue (US$ Million) & (2015-2020)
  • 5.6.5 HENGRUI MEDICINE Recent Developments

...

6 North America

• 6.1 North America Celecoxib Capsule Market Size by Country
• 6.2 United States
• 6.3 Canada

7 Europe

• 7.1 Europe Celecoxib Capsule Market Size by Country
• 7.2 Germany
• 7.3 France
• 7.4 U.K.
• 7.5 Italy
• 7.6 Russia
• 7.7 Nordic
• 7.8 Rest of Europe

8 Asia-Pacific

• 8.1 Asia-Pacific Celecoxib Capsule Market Size by Region
• 8.2 China
• 8.3 Japan
• 8.4 South Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australia
• 8.8 Rest of Asia-Pacific

9 Latin America

• 9.1 Latin America Celecoxib Capsule Market Size by Country
• 9.2 Mexico
• 9.3 Brazil
• 9.4 Rest of Latin America

10 Middle East & Africa

• 10.1 Middle East & Africa Celecoxib Capsule Market Size by Country
• 10.2 Turkey
• 10.3 Saudi Arabia
• 10.4 UAE
• 10.5 Rest of Middle East & Africa

11 Celecoxib Capsule Market Dynamics

• 11.1 Industry Trends
• 11.2 Market Drivers
• 11.3 Market Challenges
• 11.4 Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Disclaimer

Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. It may also be used to decrease the risk of colorectal adenomas in people with familial adenomatous polyposis. It is taken by mouth. Benefits are typically seen within an hour.

Market Analysis and Insights: Global Celecoxib Capsule Market
The research report studies the Celecoxib Capsule market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Celecoxib Capsule market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Celecoxib Capsule Scope and Segment
The global Celecoxib Capsule market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Celecoxib Capsule market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
50mg
100mg
200mg
400mg
by Application, this report covers the following segments
Rheumatoid Arthritis
Osteoarthritis
Acute Pain
Musculoskeletal Pain
Others
Global Celecoxib Capsule market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Celecoxib Capsule key players in this market include:
Pfizer
Teva
Mylan
Apotex
Lupin
HENGRUI MEDICINE